Mar Villamiel | Biology and Life Sciences | Women Researcher Award

Mar Villamiel | Biology and Life Sciences | Women Researcher Award

Dr Mar Villamiel, CIAL, CSIC-UAM, Spain

Dr. Mar Villamiel is the Director of CIAL (Institute of Food Science Research, CSIC-UAM) in Spain and leads the PREBIOIN research group focused on carbohydrate functionality and food bioactivity. With a PhD in Pharmacy from Complutense University of Madrid, she specializes in food technology, bioactive carbohydrates, and sustainable food preservation. Her innovative research centers on extracting and characterizing pectin and other functional ingredients from agri-food by-products. Dr. Villamiel has coordinated over 70 research projects and contracts, published 173 JCR articles (h-index: 46 WoS), co-authored 20 book chapters, and holds 7 patents. Her work has earned her national and international recognition, including being named among the Top 2% of Scientists worldwide by Stanford University. Passionate about science communication, she has presented at over 150 conferences and supervised more than 50 academic theses and internships globally. Her commitment to sustainability and technological advancement defines her as a leading force in food science research.

Publication Profile

Orcid

Education

Dr. Mar Villamiel completed her undergraduate degree in Pharmacy at Complutense University of Madrid in 1991 and earned her PhD in Pharmacy from the same institution in 1995. Her doctoral studies laid the groundwork for a highly interdisciplinary research career, incorporating analytical chemistry, food technology, and functional foods. Postdoctoral work in the Netherlands and professional exchanges in the UK expanded her knowledge in sustainable food preservation and the development of bioactive food compounds. Her deep educational foundation has supported her leadership in developing advanced methodologies in food science. Through ongoing academic collaborations and international stays, she continues to enhance her expertise and contribute to global education, mentoring students and researchers across Europe, Latin America, and beyond. Her academic path reflects a consistent trajectory of excellence, innovation, and dedication to research in food bioactivity and sustainable processing technologies. πŸŽ“πŸ”πŸ“˜πŸŒ

Experience

Dr. Villamiel has over two decades of experience in food science research, beginning her career as a Tenured Scientist at CSIC (2000–2009). She later served as Deputy Director (2017–2019) and is currently the Director of CIAL since March 2021. She leads the PREBIOIN group, which explores carbohydrate functionality, pectin extraction, and sustainable food technologies. She has led 8 international projects, 34 industry contracts, and 72 total projects, often as Principal Investigator. She has published widely, mentored numerous PhDs (including international awardees), and edited prestigious scientific journals. Her collaborations span across institutions in Europe, Latin America, and Asia. She actively participates in EU regulatory panels and scientific committees and has received 10 research awards. Her interdisciplinary approach and leadership have made significant impacts in agri-food revalorization, food preservation, and nutritional functionality.

Awards and Honors

Dr. Mar Villamiel’s outstanding contributions have earned her numerous accolades, including 10 research awards and inclusion in the Stanford–Elsevier World’s Top 2% Scientists list in 2024. She has received five positive evaluations for six-year research periods, attesting to the sustained quality and impact of her work. Her research achievements include 7 patents (2 international), 173 JCR-indexed publications, and leadership of multi-million-euro research projects. She has served as an editor for major scientific journals and been an invited speaker at 17 international conferences. Her innovative methodologies in pectin extraction and bioactive compound analysis have been recognized with top conference awards, including First Prize at the Food Chemistry Conference (2023). She represents CSIC on platforms like the Biobased Industries Consortium and Food for Life. Her awards reflect her global influence, scientific leadership, and unwavering commitment to advancing sustainable food research.

Research Focus

Dr. Villamiel’s research focuses on the chemistry and functionality of carbohydrates, particularly pectins derived from agri-food by-products. She pioneers green extraction technologies such as ultrasound and subcritical water methods to obtain high-value bioactive compounds. Her work contributes significantly to sustainable food systems, enabling revalorization of food waste and enhancing nutritional profiles of food products. She leads multiple international collaborations and has developed in vitro digestion models to study carbohydrate behavior in the human gut. Her research addresses pressing challenges in food preservation, functional ingredient development, and biorefinery approaches for the food industry. With 173 publications, a high h-index (47 Scopus), and leadership in EU and Latin American projects, she is at the forefront of innovation in food science. Her contributions support public health, environmental sustainability, and industrial competitiveness through novel bioactive food solutions.

Publication Top Notes

Binhui Zhou | Biology and Life Sciences | Best Researcher Award

Binhui Zhou | Biology and Life Sciences | Best Researcher Award

Assoc. Prof. Dr Binhui Zhou, Institute of Psychiatry and Neuroscience, China

Assoc. Prof. Dr. Binhui Zhou is a leading researcher in molecular biology and neuroscience, renowned for his work in protein palmitoylation and its implications in cancer and immune disorders πŸ”¬πŸ§ . He earned his Ph.D. in Crop Genetics and Breeding from Hainan University and currently serves as an Associate Professor at the Institute of Neuropsychiatry and Neuroscience, Xinxiang Medical University πŸŽ“πŸ₯. With over a decade of research, Dr. Zhou has pioneered studies funded by the National Natural Science Foundation of China and the Henan Provincial Foreign Expert Project πŸ‡¨πŸ‡³πŸŒŸ. His groundbreaking publications in top-tier journals have significantly advanced our understanding of cellular signaling in diseases such as hepatocellular carcinoma and atherosclerosis 🧬🩸. A highly respected peer reviewer for prestigious journals, he continues to shape the scientific community through innovation and collaboration πŸ€πŸ“š. Dr. Zhou exemplifies excellence in research and stands as a deserving candidate for the Best Researcher Award πŸ†βœ¨.

Publication Profile

Orcid

Education

Dr. Binhui Zhou’s educational journey reflects his strong commitment to bioscience and innovation πŸ“˜πŸ§ͺ. He began his academic career with a Bachelor’s degree in Bioengineering from Ningbo Institute of Technology, Zhejiang University (2005–2009) πŸŽ“πŸ”. His passion for molecular and developmental biology led him to complete a Master’s degree in Developmental Biology at Hainan University (2010–2013), where he gained key insights into cell and tissue growth processes 🌱🧫. He pursued his Ph.D. at the same university in Crop Genetics and Breeding (2013–2017), where his research laid the foundation for his later studies on genetic regulation and disease pathways 🌾🧬. Throughout his education, Dr. Zhou displayed academic excellence, research depth, and a clear focus on translating fundamental biology into clinical relevance. His multidisciplinary academic background supports his current role as a prominent scientist exploring intersections of genetics, immunology, and neuroscience πŸ”πŸ“–πŸ§ .

Experience

Dr. Zhou began his academic career in 2017 as a Lecturer at the Institute of Neuropsychiatry and Neuroscience, Xinxiang Medical University 🏫🧠. Over seven years, he demonstrated outstanding research and teaching capabilities, contributing significantly to the fields of molecular biology and neuroimmunology πŸ“šπŸ”¬. In 2024, he was promoted to Associate Professor in recognition of his impactful work on palmitoylation mechanisms and their clinical relevance in hepatocellular carcinoma and immune regulation 🧬🩺. His leadership in major research projects, such as NSFC Youth Program and Henan Foreign Expert Project, highlights his ability to lead innovative studies with real-world implications πŸŒπŸ“Š. In parallel, Dr. Zhou has served as a mentor to young scientists, shaping the next generation of researchers πŸ‘¨β€πŸ«πŸŒ±. His dedication to cross-disciplinary collaboration and translational science continues to position him at the forefront of biomedical research.

Awards and Honors

Assoc. Prof. Dr. Binhui Zhou has received national recognition for his exceptional contributions to biomedical science 🧬🌟. As a Principal Investigator, he secured prestigious research grants, including the NSFC Youth Program and the Henan Provincial Foreign Expert Project, reflecting his leadership and innovation in high-impact studies πŸ’‘πŸ§ . His work has been published in top-tier journals such as Cell Molecular Immunology, Theranostics, and Journal of Advanced Research, each with high impact factors and broad influence in global science communities πŸ“ˆπŸŒ. As an expert reviewer for journals like Communications Biology and Cell Communication and Signaling, he has helped uphold the integrity and quality of scientific publishing πŸ“˜πŸ§ͺ. Moreover, Dr. Zhou was appointed as a reviewer for the NSFC Youth Program, a mark of his standing in China’s scientific elite πŸ‡¨πŸ‡³πŸ“œ. These accolades affirm his merit for the Best Researcher Award πŸ…πŸ‘.

Research Focus

Dr. Zhou’s research primarily explores protein palmitoylation, a lipid modification process critical in regulating cellular signaling pathways in diseases such as cancer, atherosclerosis, and immune dysfunctions πŸ§ͺ🧠. He focuses on zDHHC family palmitoyltransferases, particularly zDHHC1, zDHHC2, and zDHHC6, and their roles in modulating protein function in hepatocellular carcinoma and inflammatory responses πŸ”¬πŸ§¬. His investigations have revealed mechanisms by which these enzymes control immune cell behavior and cancer cell proliferation, contributing to therapeutic target discovery πŸ’ŠπŸ”. Notably, his studies on Foxp3 palmitoylation have uncovered novel immune regulatory pathways. Dr. Zhou also examines the PI3K-Akt-mTOR axis in relation to atherosclerosis, offering insights into cardiovascular disease treatment πŸ«€πŸ“Š. His interdisciplinary approach bridges molecular biology, immunology, and neuroscience, pushing the boundaries of biomedical knowledge and guiding new treatment strategies across multiple health conditions 🀝🌍. His research stands at the forefront of cellular signaling and translational medicine πŸš€πŸ§«.

Publication Top Notes